Literature DB >> 18095882

Diet and prostate cancer risk reduction.

Eric Cheung1, Panikar Wadhera, Tanya Dorff, Jacek Pinski.   

Abstract

Prostate cancer is the most commonly diagnosed malignancy in males. The current body of literature supports the role of nutritional products in the reduction of prostate cancer. This review critically addresses the natural products with the greatest potential to reduce the risk of prostate cancer, including lycopene, vitamin E, selenium, vitamin D, soy and green tea. The toxicities of the dietary products are addressed. The direction of future studies lies in clarifying the effects of these products and exploring the biological mechanisms responsible for the prevention of prostate cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18095882     DOI: 10.1586/14737140.8.1.43

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  5 in total

1.  Differential expression of thrombospondin (THBS1) in tumorigenic and nontumorigenic prostate epithelial cells in response to a chromatin-binding soy peptide.

Authors:  Alfredo F Galvez; Liping Huang; Mark M J Magbanua; Kevin Dawson; Raymond L Rodriguez
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

2.  The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer.

Authors:  Bodo C Melnik; Swen Malte John; Pedro Carrera-Bastos; Loren Cordain
Journal:  Nutr Metab (Lond)       Date:  2012-08-14       Impact factor: 4.169

Review 3.  Cancer and Mediterranean Diet: A Review.

Authors:  Maria Chiara Mentella; Franco Scaldaferri; Caterina Ricci; Antonio Gasbarrini; Giacinto Abele Donato Miggiano
Journal:  Nutrients       Date:  2019-09-02       Impact factor: 5.717

4.  Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer.

Authors:  Mou Li; Ling Yang; Yufeng Yue; Jingxu Xu; Chencui Huang; Bin Song
Journal:  Front Oncol       Date:  2021-02-17       Impact factor: 6.244

5.  Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats.

Authors:  Jessica R Tolman; Edwin D Lephart; Kenneth Dr Setchell; Dennis L Eggett; Merrill J Christensen
Journal:  Nutr Metab (Lond)       Date:  2008-11-10       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.